Prognostic scores and biomarkers for pediatric community-acquired pneumonia: how far have we come?

References

• BradleyJSByingtonCLShahSSPediatric Infectious Diseases Society and the Infectious Diseases Society of AmericaThe management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of AmericaClin Infect Dis2011537e2521880587
   PubMed Web of Science ®Google Scholar
• EwigSCommunity-acquired pneumonia: definition, epidemiology, and outcomeSemin Respir Infect19991429410210391404
   PubMedGoogle Scholar
• British Thoracic Society Standards of Care CommitteeBritish Thoracic Society guidelines for the management of community acquired pneumonia in childhoodThorax200257suppl 1i1i2411994552
   PubMedGoogle Scholar
• MurphyTFHendersonFWClydeWAJrCollierAMDennyFWPneumonia: an eleven-year study in a pediatric practiceAm J Epidemiol1981113112216257108
   PubMed Web of Science ®Google Scholar
• JokinenCHeiskanenLJuvonenHIncidence of community-acquired pneumonia in the population of four municipalities in Eastern FinlandAm J Epidemiol199313799779888317455
   PubMed Web of Science ®Google Scholar
• ReddSCVreulsRMetsingMMohobanePHPatrickEMoteeteeMClinical signs of pneumonia in children attending a hospital outpatient department in LesothoBull World Health Organ19947211131188131246
   PubMed Web of Science ®Google Scholar
• McIntoshKCommunity-acquired pneumonia in childrenN Engl J Med200234642943711832532
   PubMed Web of Science ®Google Scholar
• PrincipiNEspositoSMycoplasma pneumoniae and Chlamydia pneumoniae cause lower respiratory tract disease in pediatric patientsCurr Opin Infect Dis20021529530012015465
   PubMed Web of Science ®Google Scholar
• Heiskanen-KosmaTKorppiMJokinenCEtiology of childhood pneumonia: serologic results of a prospective, population-based studyPediatr Infect Dis J199817119869919849979
   PubMed Web of Science ®Google Scholar
• von BaumHEwigSMarreRCompetence Network for Community Acquired Pneumonia Study GroupCommunity-acquired Legionella pneumonia: new insights from the German Competence Network for community acquired pneumoniaClin Infect Dis20084691356136418419436
   PubMed Web of Science ®Google Scholar
• van de GardeEMEndemanHvan HemertRNPrior outpatient antibiotic use as predictor for microbial aetiology of community-acquired pneumonia: hospital-based studyEur J Clin Pharmacol200864440541018060396
   PubMed Web of Science ®Google Scholar
• HuangHHZhangYYXiuQYCommunity-acquired pneumonia in Shanghai, China: microbial etiology and implications for empirical therapy in a prospective study of 389 patientsEur J Clin Microbiol Infect Dis200625636937416767484
   PubMed Web of Science ®Google Scholar
• PetoLNadjmBHorbyPThe bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic reviewTrans R Soc Trop Med Hyg2014108632633724781376
   PubMed Web of Science ®Google Scholar
• GrossmanRFCommunity-Acquired Pneumonia: Advances in ManagementACCP Pulmonary Medicine Board Review26th edGlenview, ILACCP2009
   Google Scholar
• FlorinTAAmbroggioLBiomarkers for community-acquired pneumonia in the emergency departmentCurr Infect Dis Rep2014161245125348745
   PubMed Web of Science ®Google Scholar
• KrügerSWelteTBiomarkers in community-acquired pneumoniaExpert Rev Respir Med20126220321422455492
   PubMed Web of Science ®Google Scholar
• KolditzMEwigSHöffkenGManagement-based risk prediction in community-acquired pneumonia by scores and biomarkersEur Respir J201341497498423018905
   PubMed Web of Science ®Google Scholar
• NiedermanMSMaking sense of scoring systems in community acquired pneumoniaRespirology200914332733519353770
   PubMed Web of Science ®Google Scholar
• FineMJAubleTEYealyDMA prediction rule to identify low-risk patients with community-acquired pneumoniaN Engl J Med199733642432508995086
   PubMed Web of Science ®Google Scholar
• RelloJRodriguezASeverity of illness assessment for managing community acquired pneumoniaIntensive Care Med200733122043204417938882
   PubMed Web of Science ®Google Scholar
• LimWSvan der EerdenMMLaingRDefining community acquired pneumonia severity on presentation to hospital: an international derivation and validation studyThorax200358537738212728155
   PubMed Web of Science ®Google Scholar
• CapelasteguiAEspañaPPQuintanaJMValidation of a predictive rule for the management of community-acquired pneumoniaEur Respir J20062715115716387948
   PubMed Web of Science ®Google Scholar
• BauerTTEwigSMarreRSuttorpNWelteTthe CAPNETZ GroupCRB-65 predicts death from community-acquired pneumoniaJ Intern Med200626019310116789984
   PubMed Web of Science ®Google Scholar
• NiedermanMSFeldmanCRichardsGACombining information from prognostic scoring tools for CAP: an American view on how to get the best of both worldsEur Respir J20062791116387929
   PubMed Web of Science ®Google Scholar
• AujeskyDAubleTEYealyDMProspective comparison of three validated prediction rules for prognosis in community-acquired pneumoniaAm J Med2005118438439215808136
   PubMed Web of Science ®Google Scholar
• EwigSDe RouxABauerTValidation of predictive rules and indices of severity for community acquired pneumoniaThorax200459542142715115872
   PubMed Web of Science ®Google Scholar
• NiedermanMSMandellLAAnzuetoAAmerican Thoracic SocietyGuidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and preventionAm J Respir Crit Care Med20011631730175411401897
   PubMed Web of Science ®Google Scholar
• MandellLAWunderinkRGAnzuetoAInfectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adultsClin Infect Dis200744suppl 2S27S7217278083
   PubMed Web of Science ®Google Scholar
• EspañaPPCapelasteguiAGorordoIDevelopment and validation of a clinical prediction rule for severe community-acquired pneumoniaAm J Respir Crit Care Med2006174111249125616973986
   PubMed Web of Science ®Google Scholar
• CharlesPCWolfeRWhitbyMAustralian Community-Acquired Pneumonia Study CollaborationSMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumoniaClin Infect Dis200847337538418558884
   PubMed Web of Science ®Google Scholar
• ChalmersJDSinganayagamAHillATPredicting the need for mechanical ventilation and/or inotropic support for young adults admitted to the hospital with community-acquired pneumoniaClin Infect Dis200847121571157418991510
   PubMed Web of Science ®Google Scholar
• British Thoracic SocietyMyintPKKamathAVVowlerSLMaiseyDNHarrisonBDSeverity assessment criteria recommended by the British Thoracic Society (BTS) for community-acquired pneumonia (CAP) and older patients. Should SOAR (systolic blood pressure, oxygenation, age and respiratory rate) criteria be used in older people? A compilation study of two prospective cohortsAge Ageing200635328629116638769
   PubMed Web of Science ®Google Scholar
• ArayaSLoveraDZarateCApplication of a Prognostic Scale to estimate the mortality of children hospitalized with community-acquired pneumoniaPediatr Infect Dis J201635436937326629871
   PubMed Web of Science ®Google Scholar
• RelloJRodriguezALisboaTGallegoMLujanMWunderinkRPIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumoniaCrit Care Med200937245646219114916
   PubMed Web of Science ®Google Scholar
• ConfalonieriMPotenaACarboneGDella PortaRTolleyEAMeduriGUAcute respiratory failure in patients with severe community-acquired pneumonia: a prospective randomized evaluation of noninvasive ventilationAm J Resp Crit Care Med199916051585159110556125
   PubMed Web of Science ®Google Scholar
• HoogewerfMOosterheertJJHakEHoepelmanIMBontenMJMPrognostic factors for early clinical failure in patients with severe community-acquired pneumoniaClin Microbiol Infect2006121097110417002609
   PubMed Web of Science ®Google Scholar
• SchaafBKruseJRuppJSepsis severity predicts outcome in community-acquired pneumococcal pneumoniaEur Respir J200730351752417537775
   PubMed Web of Science ®Google Scholar
• JamesJHLuchetteFAMcCarterFDFischerJELactate is an unreliable indicator of tissue hypoxia in injury or sepsisLancet1999354917750550810465191
   PubMed Web of Science ®Google Scholar
• Abd Elaziz MohamedKAbd Elgalil AhmedDPrognostic value of lactate clearance in severe community acquired pneumoniaEgypt J Chest Dis Tuberculosis201463410531058
   Google Scholar
• MoulinFRaymondJLorrotMProcalcitonin in children admitted to hospital with community acquired pneumoniaArch Dis Child200184433233611259234
   PubMed Web of Science ®Google Scholar
• ToikkaPIrjalaKJuvénTSerum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in childrenPediatr Infect Dis J200019759860210917215
   PubMed Web of Science ®Google Scholar
• KrügerSEwigSKundeJHartmannOSuttorpNWelteTPro-atrial natriuretic peptide and pro-vasopressin to predict short- and long-term survival in community-acquired pneumoniaThorax20106520821420335288
   PubMed Web of Science ®Google Scholar
• KrügerSEwigSMarreRProcalcitonin predicts patients at low risk of death from community-acquired pneumoniaEur Respir J20083134935517959641
   PubMed Web of Science ®Google Scholar
• KoivulaIStenMMakelaPPrognosis after community-acquired pneumonia in the elderly: a population-based 12-year follow-up studyArch Intern Med19991591550155510421277
   PubMedGoogle Scholar
• KrügerSEwigSGiersdorfSHartmannOSuttorpNWelteTCardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumoniaAm J Respir Crit Care Med2010182111426143420639437
   PubMed Web of Science ®Google Scholar
• CarpenterTCSchornbergSStenmarkKREndothelin-mediated increases in lung VEGF content promote vascular leak in young rats exposed to viral infection and hypoxiaAm J Physiol Lung Cell Mol Physiol2005289L1075L108216040626
   PubMed Web of Science ®Google Scholar
• MorgenthalerNGStruckJChrist-CrainMBergmannAMüllerBPro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational studyCrit Care200391R37R45
   Web of Science ®Google Scholar
• JochbergerSMorgenthalerNGMayrVDCopeptin and arginine vasopressin concentrations in critically ill patientsJ Clin Endocrinol Metab200691114381438616940457
   PubMed Web of Science ®Google Scholar
• BoussekeyNLeroyOAlfandariSDevosPGeorgesHGueryBProcalcitonin kinetics in the prognosis of severe community-acquired pneumoniaIntensive Care Med20063246947216477418
   PubMed Web of Science ®Google Scholar
• BoussekeyNLeroyOGeorgesHDevosPD’EscrivanTGueryBDiagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unitInfection200533425726316091896
   PubMed Web of Science ®Google Scholar
• Christ-CrainMStolzDBingisserRProcalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trialAm J Respir Crit Care Med20061741849316603606
   PubMed Web of Science ®Google Scholar
• MasiaMGutierrezFShumCUsefulness of procalcitonin levels in community-acquired pneumonia according to severity indexChest20051282223222916236878
   PubMed Web of Science ®Google Scholar
• HuangDTWeissfeldLAKellumJAGenIMS InvestigatorsRisk prediction with procalcitonin and clinical rules in community-acquired pneumoniaAnn Emerg Med200852485818342993
   PubMed Web of Science ®Google Scholar
• Christ-CrainMStolzDJutlaSFree and total cortisol levels as predictors of severity and outcome in community-acquired pneumoniaAm J Respir Crit Care Med2007176991392017702966
   PubMed Web of Science ®Google Scholar
• SalluhJIFBozzaFASoaresMAdrenal response in severe community-acquired pneumonia: impact on outcomes and disease severityChest200813494795418753464
   PubMed Web of Science ®Google Scholar
• ViasusDDel Rio-PertuzGSimonettiAFBiomarkers for predicting short-term mortality in community-acquired pneumonia: a systematic review and meta-analysisJ Infect201672327328226777314
   PubMed Web of Science ®Google Scholar
• AgnelloLBelliaCDi GangiMUtility of serum procalcitonin and C-reactive protein in severity assessment of community-acquired pneumonia in childrenClin Biochem2016491–2475026386341
   PubMed Web of Science ®Google Scholar
• LiJSunLXuFScreening and identification of APOC1 as a novel potential biomarker for differentiate of Mycoplasma pneumoniae in childrenFront Microbiol20167196128018301
   PubMed Web of Science ®Google Scholar
• Saghafian-HedengrenSMathewJLHagelEAssessment of cytokine and chemokine signatures as potential biomarkers of childhood community-acquired pneumonia severity: a nested cohort study in IndiaPediatr Infect Dis J201736110210827956727
   PubMed Web of Science ®Google Scholar
• EspositoSBianchiniSGambinoMMeasurement of lipocalin-2 and syndecan-4 levels to differentiate bacterial from viral infection in children with community-acquired pneumoniaBMC Pulm Med201616110327439403
   PubMed Web of Science ®Google Scholar
• GiuliaBLuisaAConcettaSBrunaLSChiaraBMarcelloCPro-calcitonin and community-acquired pneumonia (CAP) in childrenClin Chim Acta2015451pt B21521826434548
   PubMed Web of Science ®Google Scholar
• AlcobaGManzanoSLacroixLGaletto-LacourAGervaixAPro-adrenomedullin and copeptin in pediatric pneumonia: a prospective diagnostic accuracy studyBMC Infect Dis20151534726286191
   PubMed Web of Science ®Google Scholar
• WrotekAJackowskaTPawlikKSoluble urokinase plasminogen activator receptor: an indicator of pneumonia severity in childrenAdv Exp Med Biol20158351725315615
   PubMed Web of Science ®Google Scholar
• HoshinaTNanishiEKannoSNishioHKusuharaKHaraTThe utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitisJ Infect Chemother2014201061662025027057
   PubMed Web of Science ®Google Scholar
• WrotekAPawlikKJackowskaTSoluble receptor for urokinase plasminogen activator in community-acquired pneumonia in childrenAdv Exp Med Biol201378832933423835994
   PubMed Web of Science ®Google Scholar
• Sardà SánchezMHernándezJCHernández-BouSTeruelGCRodríguezJVCubellsCLPro-adrenomedullin usefulness in the management of children with community-acquired pneumonia, a preliminar(y) prospective observational studyBMC Res Notes2012536322818355
   PubMedGoogle Scholar
• EspositoSTagliabueCPicciolliIProcalcitonin measurements for guiding antibiotic treatment in pediatric pneumoniaRespir Med2011105121939194521959024
   PubMed Web of Science ®Google Scholar
• LeeJYHwangSJShimJWClinical significance of serum procalcitonin in patients with community-acquired lobar pneumoniaKorean J Lab Med201030440641320805714
   PubMedGoogle Scholar
• DonMValentFKorppiMCancianiMDifferentiation of bacterial and viral community-acquired pneumonia in childrenPediatr Int2009511919619371285
   PubMed Web of Science ®Google Scholar
• TumgorGCelikUAlabazDAetiological agents, interleukin-6, interleukin-8 and CRP concentrations in children with community- and hospital-acquired pneumoniaAnn Trop Paediatr200626428529117132293
   PubMed Web of Science ®Google Scholar
• BallinAOsadchyAKlivitskyADalalILishnerMAge-related leukocyte and cytokine patterns in community-acquired bronchopneumoniaIsr Med Assoc J20068638839016833166
   PubMed Web of Science ®Google Scholar
• KorppiMNon-specific host response markers in the differentiation between pneumococcal and viral pneumonia: what is the most accurate combination?Pediatr Int200446554555015491381
   PubMed Web of Science ®Google Scholar
• CaiQXuMYValue of neutrophil CD64 in the diagnosis of community acquired pneumonia in children]. [Article in ChineseZhongguo Dang Dai Er Ke Za Zhi2012141181982223146726
   PubMedGoogle Scholar